Price Performance of Adial Pharmaceuticals, Inc. (ADIL)
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) has experienced an interesting year when it comes to its price journey. This particular company’s stock managed to reach its 1-Year High price of $9.44, but it rose to its lowest point in the past year, $1.11.
At the end of the most recent trading day, Adial Pharmaceuticals, Inc. closed at $4.74. The stock began the trading session at $4.98 and hit a high of $5.15. The lowest price during the trading day was $4.22.
The shares of this company, which operates in the healthcare sector, reached a trading volume of about 1,430,028 throughout the day, which was clearly lower than the average daily volume for these shares.
At the time of writing, this publicly-traded organization holds a total market value of 33.75M, with 3 employees on its payroll.
Continuing forward, if we take into consideration what stock market experts are currently saying regarding Adial Pharmaceuticals, Inc.(NASDAQ:ADIL), the mean rating for this stock is 2.00. How is that calculated? Well, 0 analysts have given this company a BUY rating, 2 are rated it as OUTPERFORM, 0 have recommended that investors HOLD, 0 are considering it an UNDERPERFORM and 0 have recommended that owners of these shares SELL.
A month ago, 0 analysts thought this stock was a BUY, 2 of them posted an OUTPERFORM rating, 0 analysts recommended to HOLD this stock, 0 of them provided an underperform rating and 0 rated it as a Sell.
This company’s 100-day moving average was 3.63, while its price change was posted at +1.54. Similarly, Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) experienced a 100-day Percent movement of +48.12% with a trading volume reaching 1,104,763.
One widely-used way of understanding a particular company’s financial strength is to take its Total Debt to Equity Ratio, also known as D/E ratio, into account – a number that is found by dividing a company’s present total liabilities by its total stockholders’ equity. This metric just illustrates how much debt an organization is using to support its assets in relation to how much its shareholder’s equity is worth. ADIL’s Total Dept/Eq ratio is sitting at 0.02 at the time of writing, while its long-term Dept/Eq ratio is 0.00
While maintaining our attention on the Technical analysis of Adial Pharmaceuticals, Inc. (NASDAQ:ADIL), during the last 50 days, its Raw Stochastic average was observed 41.40%, representing an improvement from this organization’s 20-day Raw Stochastic average – which was posted 10.13%. During the last 20-days time span, this firm’s Stochastic %K was 12.58% and its Stochastic %D was noted 17.54%.